Premium
Association between ICAM‐1 Gly‐Arg polymorphism and renal parenchymal scarring following childhood urinary tract infection
Author(s) -
Gbadegesin R. A.,
Cotton S. A.,
Watson C. J.,
Brenchley P. E. C.,
Webb N. J. A.
Publication year - 2006
Publication title -
international journal of immunogenetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.41
H-Index - 47
eISSN - 1744-313X
pISSN - 1744-3121
DOI - 10.1111/j.1744-313x.2006.00565.x
Subject(s) - genotype , exon , urinary system , allele , genotyping , biology , intercellular adhesion molecule 1 , immunology , restriction fragment length polymorphism , allele frequency , cell adhesion molecule , medicine , gene , genetics , endocrinology
Summary Renal parenchymal scarring (RPS) following urinary tract infection (UTI) is an important cause of renal morbidity in children. Studies have shown that the intensity of the inflammatory response following infection is related to the risk of RPS. However, genetic variability in this response has not been studied. Adhesion molecules play a crucial role in leucocyte recruitment following infection, and polymorphisms have been reported in the genes for key cell adhesion molecules. We have investigated the possibility that children who develop RPS following UTI may exhibit altered genotype or allele frequencies for polymorphisms of the intercellular adhesion molecule‐1 (ICAM‐1) (exons 4 and 6), E‐selectin (exons 2 and 4), platelet endothelial cell adhesion molecule‐1 (PECAM‐1) (exon 3) and CD11b (3′UTR) genes, which may predict outcome of UTI. DNA was isolated from 99 children shown to have developed RPS, 43 children with no evidence of scarring (NS) following UTI and 170 healthy controls. Genotyping was performed by restriction fragment length polymorphism (RFLP) analysis. When the RPS group was compared with the NS group, there was a significant reduction in the frequency of the ICAM‐1 exon 4 A allele (10.6 vs. 21.3%, respectively, χ 2 = 6.01, P = 0.014). There was no significant difference in either allele or genotype frequency for any of the other polymorphisms studied. These data suggest that the A allele of the ICAM‐1 exon 4 polymorphism may protect against the risk of RPS following UTI and may participate in the regulation of the inflammatory response following UTI.